Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2021 | 07-2021 | 04-2021 | 01-2021 | 10-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 139 | 172 | 249 | 532 | 697 |
| Receivables | 5 | 12 | 12 | 10 | 8 |
| Inventories | 5 | 5 | 5 | N/A | N/A |
| TOTAL | $188 | $217 | $296 | $561 | $716 |
| Non-Current Assets | |||||
| PPE Net | 32 | N/A | N/A | N/A | N/A |
| Intangibles | 4,549 | 4,698 | 4,822 | 4,507 | 4,631 |
| TOTAL | $4,581 | $4,698 | $4,822 | $4,507 | $4,631 |
| Total Assets | $4,769 | $4,914 | $5,119 | $5,068 | $5,347 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 15 | 15 | 21 | 15 | 15 |
| Accounts payable and accrued liabilities | 12 | 19 | 12 | 31 | 116 |
| Accrued Expenses | 32 | 24 | 16 | 31 | 21 |
| Other current liabilities | 663 | 665 | 530 | 198 | 198 |
| TOTAL | $744 | $723 | $579 | $274 | $350 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 140 | 140 | 140 |
| TOTAL | $11 | $0 | $140 | $140 | $140 |
| Total Liabilities | $755 | $723 | $719 | $414 | $490 |
| Shareholders' Equity | |||||
| Common Shares | 9,701 | 9,701 | 9,701 | 9,701 | 9,701 |
| Retained earnings | -6,661 | -6,293 | -5,804 | -5,402 | -5,009 |
| Other shareholders' equity | 975 | 783 | 503 | 355 | 165 |
| TOTAL | $4,014 | $4,191 | $4,400 | $4,654 | $4,857 |
| Total Liabilities And Equity | $4,769 | $4,914 | $5,119 | $5,068 | $5,347 |